| Trial ID: | L0255 |
| Source ID: | NCT00227110
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: Pioglitazone|Drug: Placebo
|
| Outcome Measures: |
Liver histology (Kleiner criteria, Hepatology 2005)|Liver fat content by MRS.|Double-tracer OGTT (EGP, glucose clearance).
|
| Sponsor/Collaborators: |
The University of Texas Health Science Center at San Antonio|National Institutes of Health (NIH)|Takeda Pharmaceuticals North America, Inc.
|
| Gender: |
All
|
| Age: |
21 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
55
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
October 2002
|
| Completion Date: |
January 2006
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 14, 2009
|
| Locations: |
Audie L Murphy VA Hospital, San Antonio, Texas, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00227110
|
